MetLife, Inc. (NYSE:MET) was upgraded by analysts at TheStreet from a “c” rating to a “b-” rating in a research note issued on Monday.

Several other equities research analysts have also commented on the company. BidaskClub lowered MetLife from a “hold” rating to a “sell” rating in a research note on Monday. J P Morgan Chase & Co assumed coverage on MetLife in a research note on Monday. They issued a “hold” rating and a $78.00 price objective for the company. Wells Fargo & Company restated an “outperform” rating and issued a $63.00 price objective (up from $61.00) on shares of MetLife in a research note on Wednesday, July 12th. Royal Bank Of Canada restated a “buy” rating and issued a $62.00 price objective on shares of MetLife in a research note on Wednesday, July 12th. Finally, Citigroup Inc. set a $51.00 price objective on MetLife and gave the stock a “sell” rating in a research note on Friday, July 7th. Two equities research analysts have rated the stock with a sell rating, six have issued a hold rating, six have given a buy rating and one has issued a strong buy rating to the stock. The company presently has an average rating of “Hold” and an average price target of $59.03.

Shares of MetLife (NYSE:MET) traded down 1.74% during midday trading on Monday, hitting $54.73. The company had a trading volume of 4,266,209 shares. MetLife has a 52 week low of $38.87 and a 52 week high of $58.09. The company’s market capitalization is $58.89 billion. The firm’s 50 day moving average is $53.97 and its 200 day moving average is $53.02.

MetLife (NYSE:MET) last posted its quarterly earnings data on Wednesday, May 3rd. The financial services provider reported $1.46 EPS for the quarter, topping the consensus estimate of $1.27 by $0.19. The firm had revenue of $16.27 billion during the quarter, compared to analyst estimates of $17.02 billion. MetLife had a positive return on equity of 7.57% and a negative net margin of 0.95%. MetLife’s revenue was down 11.7% on a year-over-year basis. During the same period in the prior year, the business posted $1.20 EPS. Equities research analysts anticipate that MetLife will post $5.38 EPS for the current year.

ILLEGAL ACTIVITY WARNING: This report was published by American Banking News and is owned by of American Banking News. If you are reading this report on another publication, it was illegally copied and republished in violation of United States and international trademark & copyright legislation. The legal version of this report can be viewed at https://www.americanbankingnews.com/2017/07/26/metlife-inc-nysemet-rating-increased-to-b-at-thestreet.html.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Atria Investments LLC increased its position in MetLife by 2.6% in the first quarter. Atria Investments LLC now owns 18,914 shares of the financial services provider’s stock valued at $999,000 after buying an additional 488 shares during the period. Prospera Financial Services Inc bought a new position in MetLife during the first quarter valued at approximately $1,525,000. Tompkins Financial Corp increased its position in MetLife by 40.8% in the first quarter. Tompkins Financial Corp now owns 7,789 shares of the financial services provider’s stock valued at $342,000 after buying an additional 2,258 shares during the period. UBS Asset Management Americas Inc. increased its position in MetLife by 3.5% in the fourth quarter. UBS Asset Management Americas Inc. now owns 4,148,498 shares of the financial services provider’s stock valued at $223,563,000 after buying an additional 140,341 shares during the period. Finally, Aberdeen Asset Management PLC UK increased its position in MetLife by 1.3% in the first quarter. Aberdeen Asset Management PLC UK now owns 469,645 shares of the financial services provider’s stock valued at $24,807,000 after buying an additional 6,188 shares during the period. 74.60% of the stock is owned by institutional investors and hedge funds.

About MetLife

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings; Brighthouse Financial, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Analyst Recommendations for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife Inc. and related companies with MarketBeat.com's FREE daily email newsletter.